CSIMarket
 


Eucrates Biomedical Acquisition Corp   (EUCR)
Other Ticker:  
 
    Sector  Financial    Industry Blank Checks
   Industry Blank Checks
   Sector  Financial

Eucrates Biomedical Acquisition 's Working Capital Ratio

EUCR's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Eucrates Biomedical Acquisition 's Current Assets grew by 35.94 % in the IV Quarter 2022 sequentially, while Current Liabilities decreased, this led to improvement in Eucrates Biomedical Acquisition 's Working Capital Ratio to 2.03, Working Capital Ratio remained below Eucrates Biomedical Acquisition Corp average.

Within Blank Checks industry 70 other companies have achieved higher Working Capital Ratio than Eucrates Biomedical Acquisition in forth quarter 2022. While Working Capital Ratio total ranking has improved so far during the IV Quarter 2022 to 2676, from total ranking in the third quarter 2022 at 4189.

Explain Working Capital Ratio
How much in Current Assets EUCR´s has?
What is the value of EUCR´s Current Liabilities?


EUCR Working Capital Ratio (Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Current Liabilities Change 69.37 % 284.84 % - 1232400 % 137257.14 %
Y / Y Current Assets Change -49.95 % -80.16 % -70.23 % -59.85 % -74.14 %
Working Capital Ratio MRQ 2.03 0.81 1.1 1.81 6.87
EUCR's Total Ranking # 2676 # 4189 # 3732 # 2880 # 868
Seq. Current Liabilities Change -45.63 % -40.66 % 2.38 % 412.74 % 23.54 %
Seq. Current Assets Change 35.94 % -56.23 % -37.62 % 34.83 % -46.11 %



Working Capital Ratio forth quarter 2022 Company Ranking
Within: No.
Blank Checks Industry # 71
Financial Sector # 344
Overall Market # 2676


Working Capital Ratio Statistics
High Average Low
55437.69 10216.51 0.81
(Mar 31 2021)   (Sep 30 2022)




Financial Statements
Eucrates Biomedical Acquisition 's Current Liabilities $ 0 Millions Visit EUCR's Balance sheet
Eucrates Biomedical Acquisition 's Current Assets $ 0 Millions Visit EUCR's Balance sheet
Source of EUCR's Sales Visit EUCR's Sales by Geography


Cumulative Eucrates Biomedical Acquisition 's Working Capital Ratio

EUCR's Working Capital Ratio for the trailling 12 Months

EUCR Working Capital Ratio

(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Current Liabilities TTM Growth 69.37 % 284.84 % - 1232400 % 137257.14 %
Y / Y Current Assets TTM Growth -49.95 % -80.16 % -70.23 % -59.85 % -74.14 %
Working Capital Ratio TTM 1.38 1.69 2.84 6.96 34.3
Total Ranking TTM # 3219 # 4552 # 5502 # 5747 # 5524
Seq. Current Liabilities TTM Growth -45.63 % -40.66 % 2.38 % 412.74 % 23.54 %
Seq. Current Assets TTM Growth 35.94 % -56.23 % -37.62 % 34.83 % -46.11 %


On the trailing twelve months basis Due to drop in Current Liabilities in the IV Quarter 2022 to $0.07 millions, cumulative Working Capital Ratio decreased to 1.38 above the EUCR average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Blank Checks industry 277 other companies have achieved higher Working Capital Ratio than Eucrates Biomedical Acquisition . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 3976 to 4954.

Explain Working Capital Ratio
How much in Current Assets EUCR´s has?
What is the value of EUCR´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Blank Checks Industry # 278
Financial Sector # 424
Within the Market # 2676


trailing twelve months Working Capital Ratio Statistics
High Average Low
8.26 1.22 0.17
(Mar 31 2021)   (Jun 30 2022)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2022, within Blank Checks Industry Working Capital RatioDec 31 2022 MRQ Current AssetsDec 31 2022 MRQ Current Liabilities
Hainan Manaslu Acquisition Corp   5.10 $ 0.188  Millions$ 0.037  Millions
Arvana Inc   4.78 $ 0.142  Millions$ 0.030  Millions
Investcorp India Acquisition Corp  4.60 $ 1.146  Millions$ 0.249  Millions
Healthcare Ai Acquisition Corp   4.01 $ 0.624  Millions$ 0.156  Millions
Cactus Acquisition Corp 1 Limited  3.65 $ 0.518  Millions$ 0.142  Millions
Lf Capital Acquisition Corp Ii  3.59 $ 0.631  Millions$ 0.176  Millions
Tortoiseecofin Acquisition Corp Iii  3.32 $ 0.501  Millions$ 0.151  Millions
Waverley Capital Acquisition Corp 1  3.10 $ 1.398  Millions$ 0.451  Millions
Integral Acquisition Corporation 1  2.92 $ 0.835  Millions$ 0.286  Millions
Alphavest Acquisition Corp  2.88 $ 0.742  Millions$ 0.258  Millions
Ftac Emerald Acquisition Corp   2.87 $ 1.413  Millions$ 0.492  Millions
Tristar Acquisition I Corp   2.84 $ 0.846  Millions$ 0.298  Millions
Crescera Capital Acquisition Corp   2.84 $ 0.893  Millions$ 0.315  Millions
Pmv Consumer Acquisition Corp   2.79 $ 1.368  Millions$ 0.490  Millions
Concord Acquisition Corp Ii  2.72 $ 1.373  Millions$ 0.505  Millions
Chenghe Acquisition I Co   2.61 $ 1.274  Millions$ 0.488  Millions
Embrace Change Acquisition Corp   2.57 $ 0.404  Millions$ 0.157  Millions
Pearl Holdings Acquisition Corp  2.55 $ 0.579  Millions$ 0.227  Millions
Nabors Energy Transition Corp   2.53 $ 0.843  Millions$ 0.334  Millions
Social Capital Suvretta Holdings Corp Iv  2.51 $ 0.384  Millions$ 0.153  Millions
Social Capital Suvretta Holdings Corp Ii  2.50 $ 0.381  Millions$ 0.152  Millions
G Squared Ascend Ii Inc   2.43 $ 1.060  Millions$ 0.437  Millions
Coliseum Acquisition Corp   2.41 $ 0.472  Millions$ 0.196  Millions
Acri Capital Acquisition Corporation  2.30 $ 0.707  Millions$ 0.307  Millions
Chenghe Acquisition Co   2.27 $ 0.857  Millions$ 0.378  Millions
Relativity Acquisition Corp   2.25 $ 1.488  Millions$ 0.662  Millions
Conyers Park Iii Acquisition Corp   2.22 $ 2.327  Millions$ 1.048  Millions
Blue Whale Acquisition Corp I  2.20 $ 2.199  Millions$ 0.998  Millions
Bilander Acquisition Corp   2.10 $ 0.976  Millions$ 0.464  Millions
Screaming Eagle Acquisition Corp   2.07 $ 0.699  Millions$ 0.338  Millions

Date modified: 2023-04-14T13:42:46+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com